|
|
|
Volumn 24, Issue 1 SUPPL. 4, 1997, Pages
|
|
Outpatient chemoimmunotherapy for the treatment of metastatic melanoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARMUSTINE;
CISPLATIN;
DACARBAZINE;
GRANISETRON;
ONDANSETRON;
RECOMBINANT ALPHA2A INTERFERON;
RECOMBINANT INTERLEUKIN 2;
TAMOXIFEN;
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
INTERLEUKIN 2;
RECOMBINANT PROTEIN;
ADULT;
AGED;
ANEMIA;
ANTINEOPLASTIC ACTIVITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DOSE RESPONSE;
FEMALE;
FEVER;
HUMAN;
INTERSTITIAL PNEUMONIA;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MELANOMA;
METASTASIS;
NAUSEA;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
VOMITING;
AMBULATORY CARE;
ARTICLE;
IMMUNOTHERAPY;
MIDDLE AGED;
SKIN TUMOR;
TREATMENT OUTCOME;
ADULT;
AGED;
AMBULATORY CARE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARMUSTINE;
CISPLATIN;
DACARBAZINE;
HUMANS;
IMMUNOTHERAPY;
INTERFERON-ALPHA;
INTERLEUKIN-2;
MALE;
MELANOMA;
MIDDLE AGED;
NEOPLASM METASTASIS;
RECOMBINANT PROTEINS;
SKIN NEOPLASMS;
TAMOXIFEN;
TREATMENT OUTCOME;
|
|
EID: 0031064875
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (28)
|
|
References (21)
|
